The Chromatin Landscape of Kaposi’s Sarcoma-Associated Herpesvirus
Viruses, 2013 Kaposi’s sarcoma-associated herpesvirus is an oncogenic γ-herpesvirus that causes latent infection in humans. In cells, the viral genome adopts a highly organized chromatin structure, which is controlled by a wide variety of cellular and viral chromatin ...
Zsolt Tóth, Jae Jung, Kevin Brulois
exaly +4 more sources
Targeting Kaposi’s sarcoma associated herpesvirus encoded protease (ORF17) by a lysophosphatidic acid molecule for treating KSHV associated diseases [PDF]
Frontiers in Cell and Developmental Biology, 2023 Kaposi’s sarcoma associated herpesvirus (KSHV) is causative agent of Kaposi’s sarcoma, Multicentric Castleman Disease and Pleural effusion lymphoma. KSHV-encoded ORF17 encodes a protease which cleaves -Ala-Ala-, -Ala-Ser- or -Ala-Thr-bonds.
Misbahuddin M Rafeeq +12 more
doaj +2 more sources
Kaposi’s Sarcoma-associated herpesvirus microRNAs [PDF]
Frontiers in Microbiology, 2012 Kaposi’s Sarcoma-associated herpesvirus (KSHV) is a human pathogenic -herpesvirus strongly associated with the development of Kaposi’s Sarcoma and B cell proliferative disorders, including primary effusion lymphoma (PEL).
Eva eGottwein
doaj +2 more sources
Kaposi’s Sarcoma-associated Herpesvirus [PDF]
Berkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology), 2016 Background: Kaposi’s sarcoma (KS) revealed by Moritz Kaposi first time in 1872. In the early 1980, the prevalence of SK began to increase dramatically.
Novia Indriyani Adisty +2 more
doaj +2 more sources
Mycosis fungoides and Kaposi’s sarcoma association in an HIV-negative patient [PDF]
Anais Brasileiros de Dermatologia, 2016 The association of mycosis fungoides and kaposi’s sarcoma in HIV-negative patients is a rare phenomenon. The presence of human herpesvirus 8 (HHV-8) – associated with all forms of Kaposi’s sarcoma – has also been recently identified in mycosis fungoides ...
Maria Carolina Prado Fleury Bariani +4 more
doaj +1 more source
Kaposi’s sarcoma associated with chronic myeloid leukemia and imatinib mesylate therapy
Clinical Case Reports, 2022 Kaposi's sarcoma is associated with immunosuppression and human herpesvirus 8 infection, while rarely described in myeloid malignancies. Here, we illustrate a rare case of chronic myeloid leukemia treated with imatinib, a tyrosine kinase inhibitor, who ...
Matteo D’Addona +6 more
doaj +1 more source
Pulmonary Kaposi's sarcoma—an atypical clinical presentation
International Journal of Infectious Diseases, 2022 HIV-associated Kaposi's sarcoma is an angioproliferative neoplasia caused by infection with human herpesvirus 8. It typically presents with mucocutaneous involvement. Pulmonary Kaposi's sarcoma is rare, and an uncommon form of initial presentation of the
Ana Luísa Ramos +4 more
doaj +1 more source
Kaposi's sarcoma-associated herpesvirus at 27
Tumour Virus Research, 2021 Kaposi's sarcoma-associated herpesvirus (KSHV) was discovered 27 years ago and its link to several pathologies – Kaposi's sarcoma, primary effusion lymphoma, and the B cell variant of Multicentric Castleman disease – is now well established.
Marta Maria Gaglia
doaj +1 more source
Disseminated HIV-Associated Kaposi’s Sarcoma With High CD4 Cell Count And Low Viral Load
Galicia Clínica, 2017 Kaposi’s sarcoma is considered an acquired immunodeficiency syndrome-defining illness and is caused by human herpesvirus 8. It has been associated with patients infected with human immunodeficiency virus (HIV) who have CD4 T lymphocytes
Diana Pereira Anjos +3 more
doaj +1 more source
Non-detection of human herpesvirus 8 (HHV-8) DNA in HHV-8-seropositive blood donors from three Brazilian regions. [PDF]
PLoS ONE, 2011 Human herpesvirus 8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV), is the etiologic agent of all forms of Kaposi's sarcoma, primary effusion lymphoma and the plasmablastic cell variant of multicentric Castleman disease. In endemic
José Eduardo Levi +6 more
doaj +1 more source